Fidelity Investments’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-741,276
Closed -$4.17M 2777
2016
Q1
$4.17M Sell
741,276
-418,595
-36% -$2.36M ﹤0.01% 2209
2015
Q4
$20M Hold
1,159,871
﹤0.01% 1696
2015
Q3
$24.5M Hold
1,159,871
﹤0.01% 1577
2015
Q2
$57.4M Buy
1,159,871
+70,450
+6% +$3.49M 0.01% 1280
2015
Q1
$85.3M Buy
1,089,421
+28,023
+3% +$2.19M 0.01% 1095
2014
Q4
$64.3M Buy
1,061,398
+48,310
+5% +$2.93M 0.01% 1213
2014
Q3
$43.2M Buy
1,013,088
+20,930
+2% +$892K 0.01% 1362
2014
Q2
$61.3M Buy
992,158
+300,970
+44% +$18.6M 0.01% 1258
2014
Q1
$44.9M Buy
691,188
+382,433
+124% +$24.9M 0.01% 1380
2013
Q4
$17.4M Sell
308,755
-236,240
-43% -$13.3M ﹤0.01% 1768
2013
Q3
$33.5M Buy
544,995
+183,590
+51% +$11.3M 0.01% 1464
2013
Q2
$21.1M Buy
+361,405
New +$21.1M ﹤0.01% 1644